Studies on heparin and lipemia clearing factor; inhibition towards clearing in plasma from normal and atherosclerotic individuals.
作者信息
ANGERVALL G, HOOD B
出版信息
Acta Med Scand. 1957 Jun 5;157(5):407-15.
PMID:13434786
Abstract
摘要
相似文献
1
Studies on heparin and lipemia clearing factor; inhibition towards clearing in plasma from normal and atherosclerotic individuals.
Acta Med Scand. 1957 Jun 5;157(5):407-15.
2
Serum lipemia: an overlooked cause of tissue hypoxia.
Cardiology. 1983;70(5):273-9. doi: 10.1159/000173604.
3
Effect of small doses of heparin in increasing the translucence of plasma during alimentary lipemia; studies in normal persons and patients having arteriosclerosis.
Circulation. 1951 Nov;4(5):674-8. doi: 10.1161/01.cir.4.5.674.
4
[Influences of postprandial lipemia on the plasma antithrombin content in normal and atherosclerotic subjects].
Nouv Rev Fr Hematol. 1967 Jul-Aug;7(4):565-7.
5
6
In vivo studies of the role of albumin in endogenous and heparin-activated lipemia-clearing in nephrotic rats.
J Clin Invest. 1957 May;36(5):700-5. doi: 10.1172/JCI103472.
7
[Effect of hyperlipemia & certain clearing factors on erythrosedimentation rate in autoplasma & in pectin in atherosclerotic subjects].
Gazz Med Ital. 1959 May;118(5):207-10.
8
Studies on heparin and the lipemia clearing factor. I.
Scand J Clin Lab Invest. 1954;6(1):1-7.
9
Mucopolysaccarides, clearing factor, age, and arteriosclerosis.
Bull Schweiz Akad Med Wiss. 1957 Apr;13(1-4):209-28.
10
The quantitative measurement of heparin-induced lipemia clearing activity of plasma.
J Lab Clin Med. 1954 Mar;43(3):445-51.
引用本文的文献
1
The removal of lipoprotein lipase from the blood by the normal and diseased liver.
J Clin Invest. 1959 Oct;38(10 Pt 1-2):1746-55. doi: 10.1172/JCI103953.
Zotero 插件